Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BioSpecifics Technologies Corp

+ Add to Watchlist

BSTC:US

37.7900 USD 0.1200 0.32%

As of 14:30:55 ET on 04/28/2015.

Snapshot for BioSpecifics Technologies Corp (BSTC)

Open: 37.8900 Day's Range: 35.1600 - 38.0900 Volume: 68,901
Previous Close: 37.6700 52wk Range: 22.2300 - 42.0000 1-Yr Rtn: +62.47%

Stock Chart for BSTC

No chart data available.
  • BSTC:US 37.7900
  • 1D
  • 1M
  • 1Y
37.6700
Interactive BSTC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BSTC

Current P/E Ratio (ttm) 54.9242
Estimated P/E(12/2015) -
Relative P/E vs. SPX 3.0763
Earnings Per Share (USD) (ttm) 0.6600
Est. EPS (USD) (12/2015) -
Est. PEG Ratio -
Market Cap (M USD) 244.42
Shares Outstanding (M) 6.74
30 Day Average Volume 28,661
Price/Book (mrq) 8.4064
Price/Sale (ttm) 17.4356
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BSTC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BSTC

BioSpecifics Technologies Corp. is a biopharmaceutical company. The Company developed and licensed injectable collagenase for the treatment of Dupuytren's disease, Peyronie's disease, and adhesive capsulitis (frozen shoulder).

Thomas L WegmanPresident/CEO/CFO/Secretary
More Company Profile & Key Executives for BSTC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil